A detailed history of Ethos Financial Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ethos Financial Group, LLC holds 252 shares of REGN stock, worth $180,046. This represents 0.05% of its overall portfolio holdings.

Number of Shares
252
Previous 241 4.56%
Holding current value
$180,046
Previous $267,000 1.12%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$1024.09 - $1201.76 $11,264 - $13,219
11 Added 4.56%
252 $264,000
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $212,851 - $258,156
241 New
241 $267,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ethos Financial Group, LLC Portfolio

Follow Ethos Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethos Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ethos Financial Group, LLC with notifications on news.